Pilot bioequivalence study for ELI-201 [Oxycodone/naltrexone]

Trial Profile

Pilot bioequivalence study for ELI-201 [Oxycodone/naltrexone]

Phase of Trial: Phase I

Latest Information Update: 07 Dec 2013

At a glance

  • Drugs Oxycodone/naltrexone (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Elite Pharmaceuticals
  • Most Recent Events

    • 07 Dec 2013 New trial record
    • 06 Dec 2013 The first subject has been dosed, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top